FDA Circular No. 2021-008 || Updated Guidelines for the Registration of Drug Products under Emergency Use (DEU) for COVID-19

OBJECTIVE:

This Circular aims to provide streamlined requirements and application process
for the registration of Drug Products for COVID-19.